NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Structured Abstract
Objective:
To assess efficacy, comparative effectiveness, and harms of psychological and pharmacological treatments for adults with posttraumatic stress disorder (PTSD) and to update the original 2013 review.
Data sources:
MEDLINE®, CINAHL®, Cochrane Library, Cochrane Clinical Trials Registry, PILOTS (Published International Literature on Traumatic Stress), PsycINFO®, and reference lists of published literature (May 2012–September 2017).
Review methods:
Two investigators independently selected, extracted data from, and rated risk of bias of relevant studies. We conducted meta-analyses or network meta-analyses using random-effects models when we had evidence from three or more studies with low heterogeneity. We graded strength of evidence (SOE) following established Agency for Healthcare Research and Quality guidance.
Results:
We included 193 randomized controlled trials (207 articles) for this review. Several psychological treatments were associated with the reduction of PTSD symptoms and loss of PTSD diagnosis compared with inactive comparators; high SOE supports efficacy of cognitive behavioral therapy (CBT)-exposure and CBT-mixed treatments, and moderate SOE supports efficacy of cognitive processing therapy (CPT), cognitive therapy (CT), eye movement desensitization and reprocessing (EMDR), and narrative exposure therapy (NET). When directly comparing two treatments of interest, moderate SOE favors CBT-exposure over relaxation therapy.
Several pharmacological treatments reduced PTSD symptoms; moderate SOE supports the efficacy of fluoxetine, paroxetine, and venlafaxine compared with placebo. Our network meta-analysis (33 trials; N=4,817) of Clinician-Administered PTSD Scale (CAPS)-measured PTSD symptoms showed no differences in effectiveness between medications with at least moderate SOE of efficacy (fluoxetine, paroxetine, and venlafaxine) (low SOE for no difference).
Studies provided insufficient strength of evidence for serious adverse events associated with any treatments of interest. The majority of psychological studies reported no information about adverse events. Among pharmacological treatments with evidence of efficacy (moderate SOE), we found increased risk of nausea with venlafaxine compared with placebo (moderate SOE).
Our review found insufficient strength of evidence for the comparative effectiveness of any psychological versus pharmacological treatment and for differences in the efficacy or comparative effectiveness of treatments by patient characteristics (e.g., co-occurring conditions) or type, number, severity, or chronicity of trauma exposure(s). We did not find evidence for many of our outcomes of interest or interventions of interest, including the newer treatments added since our prior review.
Conclusions:
Several psychological and pharmacological treatments have moderate to high SOE of efficacy for treating adults with PTSD. Future research is needed on the comparative effectiveness of treatments (including different comparisons of psychological and pharmacological treatments), differences in treatment benefits by trauma type or other patient characteristics, and adverse events associated with treatments.
Contents
- Key Messages
- Preface
- Acknowledgments
- Evidence Summary
- Introduction
- Methods
- Results
- Results of Literature Searches
- KQ 1. Efficacy and Comparative Effectiveness of Different Psychological Treatments
- KQ 1a. Variability in Efficacy or Comparative Effectiveness of Psychological Interventions by Patient Characteristics or Type of Trauma
- KQ 2. Efficacy and Comparative Effectiveness of Different Pharmacological Treatments
- KQ 2a. Variability in Efficacy or Comparative Effectiveness of Pharmacological Interventions by Patient Characteristics or Type of Trauma
- KQ 3. Psychotherapy Versus Pharmacotherapy for Adults With PTSD
- KQ 3a. Variability in Comparative Effectiveness of Psychological Versus Pharmacological Interventions by Patient Characteristics or Type of Trauma
- KQ 4. Adverse Effects of Treatments for PTSD
- Contextual Question (CQ) 1a. Components of Effective Psychological Treatments
- CQ 1b. Degree of Fidelity of Psychological Interventions Effective in Trial Settings When Implemented in Clinical Practice Settings
- Discussion
- Appendix A. Intervention Descriptions
- Appendix B. Outcome Measures and Instruments
- Appendix C. Search Strategy
- Appendix D. Excluded Studies
- Appendix E. Risk of Bias Assessment
- Appendix F. Study Characteristics and Findings
- Appendix G. Documentation of Trials Rated High Risk of Bias
- Appendix H. Meta-Analysis Forest Plots
- Appendix I. Strength of Evidence
- Appendix J. Expert Guidance and Review
- Appendix K. PCORI Checklist
- Report References
Suggested citation:
Hoffman V, Middleton JC, Feltner C, Gaynes BN, Weber RP, Bann C, Viswanathan M, Lohr KN, Baker C, Green J. Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update. Comparative Effectiveness Review No. 207. (Prepared by the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center under Contract No. 290-2015-00011-I for AHRQ and PCORI.) AHRQ Publication No. 18-EHC011-EF. PCORI Publication No. 2018-SR-01. Rockville, MD: Agency for Healthcare Research and Quality; May 2018. Posted final reports are located on the Effective Health Care Program search page. DOI: https://doi.org/10.23970/AHRQEPCCER207.
This report is based on research conducted by the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-2015-00011-I). The Patient-Centered Outcomes Research Institute (PCORI) funded the report (PCORI Publication No. 2018-SR-01). The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ or PCORI. Therefore, no statement in this report should be construed as an official position of PCORI, AHRQ, or of the U.S. Department of Health and Human Services.
None of the investigators have any affiliations or financial involvement that conflicts with the material presented in this report.
The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Anyone who makes decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information, i.e., in the context of available resources and circumstances presented by individual patients.
This report is made available to the public under the terms of a licensing agreement between the author and AHRQ. This report may be used and reprinted without permission except those copyrighted materials that are clearly noted in the report. Further reproduction of those copyrighted materials is prohibited without the express permission of copyright holders.
PCORI, AHRQ, or U.S. Department of Health and Human Services endorsement of any derivative products that may be developed from this report, such as clinical practice guidelines, other quality enhancement tools, or reimbursement or coverage policies, may not be stated or implied.
This report may periodically be assessed for the currency of conclusions. If an assessment is done, the resulting surveillance report describing the methodology and findings will be found on the Effective Health Care Program Web site at: www.effectivehealthcare.ahrq.gov. Search on the title of the report.
Persons using assistive technology may not be able to fully access information in this report. For assistance contact vog.shh.qrha@cpe.
- NLM CatalogRelated NLM Catalog Entries
- Review Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)[ 2013]Review Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)Jonas DE, Cusack K, Forneris CA, Wilkins TM, Sonis J, Middleton JC, Feltner C, Meredith D, Cavanaugh J, Brownley KA, et al. 2013 Apr
- Review Interventions for the Prevention of Posttraumatic Stress Disorder (PTSD) in Adults After Exposure to Psychological Trauma[ 2013]Review Interventions for the Prevention of Posttraumatic Stress Disorder (PTSD) in Adults After Exposure to Psychological TraumaGartlehner G, Forneris CA, Brownley KA, Gaynes BN, Sonis J, Coker-Schwimmer E, Jonas DE, Greenblatt A, Wilkins TM, Woodell CL, et al. 2013 Apr
- Review Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis.[Clin Psychol Rev. 2016]Review Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis.Cusack K, Jonas DE, Forneris CA, Wines C, Sonis J, Middleton JC, Feltner C, Brownley KA, Olmsted KR, Greenblatt A, et al. Clin Psychol Rev. 2016 Feb; 43:128-41. Epub 2015 Nov 2.
- Review Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents (Review).[Evid Based Child Health. 2013]Review Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents (Review).Gillies D, Taylor F, Gray C, O'Brien L, D'Abrew N. Evid Based Child Health. 2013 May; 8(3):1004-116.
- Review Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults[ 2019]Review Adverse Effects of Pharmacologic Treatments of Major Depression in Older AdultsSobieraj DM, Baker WL, Martinez BK, Hernandez AV, Coleman CI, Ross JS, Berg KM, Steffens DC. 2019 Mar
- Psychological and Pharmacological Treatments for Adults With Posttraumatic Stres...Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update
Your browsing activity is empty.
Activity recording is turned off.
See more...